Bioporto AS - Class B BIOPOR

COP: BIOPOR | ISIN: DK0011048619   5/05/2025
1,590 DKK (+0,63%)
(+0,63%)   5/05/2025

8 mei 2025 · Continued progress on key strategic milestones in Q1 2025. Total revenue in line with expectations and guidance for 2025 maintained. · Persbericht

28 april 2025 · Grant of Warrants · Persbericht

25 april 2025 · Managers’ transactions · Persbericht

25 april 2025 · BioPorto A/S raises DKK 33.5 million in new capital round - Change of number of shares and votes · Persbericht

15 april 2025 · Correction: Private placement of 25,000,000 new shares fully subscribed – gross proceeds of DKK 33.5 million, to BioPorto A/S · Persbericht

15 april 2025 · Private placement of 25,000,000 new shares fully subscribed – gross proceeds of DKK 33.5 million, to BioPorto A/S · Persbericht

14 april 2025 · BioPorto A/S initiates a private placement of up to 25,000,000 new shares at market price. The Board of Directors has received advance indications for the full offering which is expected to raise proceeds of DKK 33.5 million. · Persbericht

11 april 2025 · Resolutions of the Annual General Meeting · Persbericht

1 april 2025 · Updated biographies for board candidates at the upcoming Annual General Meeting · Persbericht

20 maart 2025 · Notice convening the Annual General Meeting in BioPorto A/S · Persbericht

20 maart 2025 · BioPorto announces the Annual Report for 2024 · Persbericht

19 maart 2025 · BioPorto announces guidance for 2025 and aspirations for 2026 towards 2029 · Persbericht

4 maart 2025 · BioPorto A/S announces Jens Due Olsen as a Board of Directors candidate intending to appoint Jens Due Olsen as Chair, along with updates on other candidates · Persbericht

27 februari 2025 · Strengthening of Investor Focus – BioPorto enters Market Maker Agreement with Danske Bank & appoints New Head of Investor Relations · Persbericht

29 januari 2025 · BioPorto A/S appoints new interim Chairman of the Board · Persbericht

6 januari 2025 · Preliminary Financial Figures for the 2024 Fiscal Year · Persbericht

16 december 2024 · BioPorto commences process to appoint new Chair of the Board of Directors  · Persbericht

14 november 2024 · BioPorto Announces Interim Results and Business Update for the Third Quarter and Nine Months of Fiscal 2024 · Persbericht

4 november 2024 · Grant of Warrants · Persbericht

29 oktober 2024 · First Patient In - BioPorto Initiates Patient Enrollment for US Study of ProNephro AKI (NGAL)™ for Adult Use at Massachusetts General Hospital · Persbericht

Mijn selecties